A hospital-based study: Risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy


Benbir G., Ozekmekci S., Apaydin H., Delil S., Erginoz E.

CLINICAL NEUROLOGY AND NEUROSURGERY, vol.108, no.8, pp.726-732, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

Abstract

Objectives: Although levodopa (LD) is the gold standard therapy for symptomatic treatment of Parkinson's disease (PD), the chronic use of LD leads to the development of motor complications in almost all patients.